A novel natural polysaccharide dissolving microneedle capable of adsorbing pus to load EGCG for the treatment of acne vulgaris
Source abstract
Abstract
Acne vulgaris is a common inflammatory skin disease associated with Propionibacterium acnes (P. acnes), with serious physical and psychological effects on patients. Conventional topical use of antibiotics is not effective due to the skin barrier and oral administration can adversely affect the intestinal flora. Microneedle is a novel type of localized drug delivery system that noninvasively breaks through the stratum corneum barrier and effectively enhances the transdermal absorption of drugs. Here, Bletilla striata polysaccharide (BSP)/Hyaluronic acid (HA) loaded Epigallocatechin gallate (EGCG) was used as the microneedle body to easily penetrate the epidermis and enhance antibacterial ability. Polyvinyl alcohol (PVA) and Diatomaceous earth (DE) are used as the microneedle backing to absorb pus and bacterial debris, prevent re-infection of bacteria and promote skin healing. Compared to traditional antibiotics, the excellent skin permeability of EGCG @ BSP/ HA MNs studied here can improve the efficacy and solve side effects and drug resistance. In vivo studies in mice models induced by P. acnes showed that this microneedle could effectively reduce skin swelling, inhibit bacterial growth and reduce the levels of TNF-α, IL-8 and MMP-2. In summary, this study provides an ideal antimicrobial drug delivery system for the treatment of acne vulgaris.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Dermatology and Skin Diseases · Acne and Rosacea Treatments and Effects · Advancements in Transdermal Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (65)
Show source-provided references
1. Acne vulgaris10.1016/S0140-6736(11)60321-8 ↗
2. Targeting inflammation in acne: current treatments and future prospects10.1007/s40257-023-00789-1 ↗
3. What is the pathogenesis of acne?10.1111/j.0906-6705.2005.0285a.x ↗
4. Propionibacterium acnes and lipopolysaccharide induce the expression of antimicrobial peptides and proinflammatory cytokines/chemokines in human sebocytes10.1016/j.micinf.2006.04.001 ↗
5. Emerging insights into the applicability of essential oils in the management of acne vulgaris10.3390/molecules28176395 ↗
6. Antimicrobial production by perifollicular dermal preadipocytes is essential to the pathophysiology of acne
7. Cutibacterium acnes(Propionibacterium acnes) and acne vulgaris: a brief look at the latest updates10.1111/jdv.15043 ↗
8. Acne as a chronic systemic disease10.1016/j.clindermatol.2013.11.005 ↗
9. Treatment of acne in pregnancy10.3122/jabfm.2016.02.150165 ↗
10. Bio-based topical system for enhanced salicylic acid delivery: preparation and performance of gels10.1111/jphp.12582 ↗
11. Microneedle-Assisted topical delivery of photodynamically active mesoporous formulation for combination therapy of deep-seated melanoma10.1021/acsnano.8b03007 ↗
12. Microneedles: a smart approach and increasing potential for transdermal drug delivery system10.1016/j.biopha.2018.10.078 ↗
13. Microneedle, bio-microneedle and bio-inspired microneedle: a review10.1016/j.jconrel.2017.02.011 ↗
14. Panorama of dissolving microneedles for transdermal drug delivery10.1016/j.lfs.2021.119877 ↗
15. Dissolving microneedles: applications and growing therapeutic potential10.1016/j.jconrel.2022.05.045 ↗
16. Chemical characterization and gastroprotective effect of an isolated polysaccharide fraction from Bletilla striata against ethanol-induced acute gastric ulcer10.1016/j.fct.2019.05.047 ↗
17. Bioresponsive nanoarchitectonics-integrated microneedles for amplified chemo-photodynamic therapy against acne vulgaris10.1021/acsami.1c15673 ↗
18. Microneedle-mediated transdermal drug delivery for treating diverse skin diseases10.1016/j.actbio.2020.12.004 ↗
19. High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris10.1001/jamadermatol.2013.6746 ↗
20. Isotretinoin use and the risk of inflammatory bowel disease: a case-control study10.1038/ajg.2010.124 ↗
21. Adverse effects of isotretinoin: a retrospective review of 1743 patients started on isotretinoin10.1111/j.1440-0960.2010.00657.x ↗
22. Characterization and evaluation of Bletilla striata polysaccharide/ethanol extract composite multifunctional sponges10.1016/j.matdes.2021.109806 ↗
23. Extraction, characterization, utilization as wound dressing and drug delivery of Bletilla striata polysaccharide: a review10.1016/j.ijbiomac.2018.09.028 ↗
24. Bletilla striata: medicinal uses, phytochemistry and pharmacological activities10.1016/j.jep.2016.11.026 ↗
25. A novel hydrogel based on Bletilla striata polysaccharide for rapid hemostasis: synthesis, characterization and evaluation10.1016/j.ijbiomac.2021.11.166 ↗
26. A review of isolation, chemical properties, and bioactivities of polysaccharides from bletilla striata
27. Photothermal-promoted multi-functional dual network polysaccharide hydrogel adhesive for infected and susceptible wound healing10.1016/j.carbpol.2021.118557 ↗
28. Novel Bletilla striata polysaccharide microneedles: fabrication, characterization, and in vitro transcutaneous drug delivery10.1016/j.ijbiomac.2018.05.097 ↗
29. Polysaccharides from tubers of Bletilla striata: physicochemical characterization, formulation of buccoadhesive wafers and preliminary study on treating oral ulcer10.1016/j.ijbiomac.2018.09.050 ↗
30. Optimization of infrared-assisted extraction of Bletilla striata polysaccharides based on response surface methodology and their antioxidant activities10.1016/j.carbpol.2016.04.081 ↗
31. Fabrication and characterization of PVA@PLA electrospinning nanofibers embedded with Bletilla striata polysaccharide and Rosmarinic acid to promote wound healing10.1016/j.ijbiomac.2023.123693 ↗
32. Bletilla striata polysaccharide microneedle for effective transdermal administration of model protein antigen10.1016/j.ijbiomac.2022.02.116 ↗
33. Therapeutic effects of EGCG: a patent review10.1080/13543776.2016.1203419 ↗
34. Skin protective effect of epigallocatechin gallate10.3390/ijms19010173 ↗
35. Anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea10.1111/bph.12009 ↗
36. Epigallocatechin-3-Gallate suppresses IGF-I-induced lipogenesis and cytokine expression in SZ95 sebocytes10.1038/jid.2012.202 ↗
37. Green tea and other tea polyphenols: effects on sebum production and acne vulgaris10.3390/antiox6010002 ↗
38. Epigallocatechin-3-gallate improves acne in humans by modulating intracellular molecular targets and inhibiting P. acnes10.1038/jid.2012.292 ↗
39. Natural diatom biosilica as microshuttles in drug delivery systems10.3390/pharmaceutics11100537 ↗
40. Diatom silica for biomedical applications: recent progress and advances10.1002/adhm.201800552 ↗
41. ROS-responsive microneedle patch for acne vulgaris treatment
42. Novel probiotic-bound oxidized Bletilla striata polysaccharide-chitosan composite hydrogel10.1016/j.msec.2020.111265 ↗
43. Physical dual-network photothermal antibacterial multifunctional hydrogel adhesive for wound healing of drug-resistant bacterial infections synthesized from natural polysaccharides10.1016/j.carbpol.2023.120831 ↗
44. A novel hyaluronic acid-based dissolving microneedle patch loaded with ginsenoside Rg3 liposome for effectively alleviate psoriasis10.1016/j.matdes.2022.111363 ↗
45. Franz diffusion cell approach for pre-formulation characterisation of ketoprofen semi-solid dosage forms10.3390/pharmaceutics10030148 ↗
46. Combination of transdermal patches and solid microneedles for improved transdermal delivery of primaquine10.1016/j.ijpharm.2021.121204 ↗
47. In vitro investigation of enhanced hemocompatibility and endothelial cell proliferation associated with quinone-rich polydopamine coating10.1021/am3027635 ↗
48. Biocompatible and biodegradable Bletilla striata polysaccharides hydrogels crosslinked by BDDE for wound healing through the regulating of macrophage polarization10.1016/j.ijbiomac.2023.128015 ↗
49. Extraction and characterization of chitosan from Eupolyphaga sinensis Walker and its application in the preparation of electrospinning nanofiber membranes10.1016/j.colsurfb.2022.113030 ↗
50. Active pharmaceutical ingredient poly(ionic liquid)-based microneedles for the treatment of skin acne infection10.1016/j.actbio.2020.08.023 ↗
51. Gallium(III)-mediated dual-cross-linked alginate hydrogels with antibacterial properties for promoting infected wound healing10.1021/acsami.2c02497 ↗
52. Dynamic evaluation of pathological changes in a mouse acne model by optical imaging technology10.1111/exd.14826 ↗
53. Topical phage therapy in a mouse model of Cutibacterium acnes-induced acne-like lesions10.1038/s41467-023-36694-8 ↗
54. Propionibacterium acnes–induced immunopathology correlates with health and disease association10.1172/jci.insight.124687 ↗
55. Ultrasound-triggered interfacial engineering-based microneedle for bacterial infection acne treatment10.1126/sciadv.adf0854 ↗
56. Strategy for osteoarthritis therapy: improved the delivery of triptolide using liposome-loaded dissolving microneedle arrays10.1016/j.ijpharm.2021.121211 ↗
57. Microneedles mediated bioinspired lipid nanocarriers for targeted treatment of alopecia10.1016/j.jconrel.2020.11.038 ↗
58. Epigallocatechin gallate/L-ascorbic acid–loaded poly-γ-glutamate microneedles with antioxidant, anti-inflammatory, and immunomodulatory effects for the treatment of atopic dermatitis10.1016/j.actbio.2021.05.032 ↗
59. Research techniques made simple: transepidermal water loss measurement as a research tool10.1016/j.jid.2018.09.001 ↗
60. Comprehensive characterization of the structure and properties of human stratum corneum relating to barrier function and skin hydration: modulation by a moisturizer formulation10.1111/exd.14331 ↗
61. TEWL measurements as a routine method for evaluating the integrity of epidermis sheets in static franz type diffusion cells in vitro limitations shown by transport data testing10.1016/j.ejpb.2005.10.009 ↗
62. Multifunctional covalent organic framework-based microneedle patch for melanoma treatment
63. Co-delivery of triamcinolone acetonide and verapamil for synergistic treatment of hypertrophic scars via carboxymethyl chitosan and Bletilla striata polysaccharide-based microneedles10.1016/j.carbpol.2022.119219 ↗
64. Hyaluronic acid-based dissolving microneedle patch loaded with methotrexate for improved treatment of psoriasis10.1021/acsami.9b15668 ↗
65. Acne vulgaris: role of the immune system10.1111/ijd.15415 ↗